Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 3.27% | 29.07 | 14.1% | $171.05m | |
| ICLR | ICON plc | 0.93% | 229.20 | 4.2% | $156.70m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.57% | 179.17 | 2.2% | $142.15m | |
| HZNP | Horizon Therapeutics Plc | 5.02% | 92.14 | 5.5% | $124.53m | |
| CTLT | Catalent, Inc. | 2.18% | 102.67 | 2.1% | $105.63m | |
| BHC | Bausch Health Cos., Inc. | 3.27% | 29.07 | 0.0% | $91.68m | |
| SAVA | Cassava Sciences, Inc. | 8.31% | 40.92 | 0.0% | $55.78m | |
| UTHR | United Therapeutics Corp. | 2.12% | 197.87 | 14.0% | $55.65m | |
| PRGO | Perrigo Co. Plc | 1.80% | 45.82 | 6.9% | $49.71m | |
| BLRX | BioLineRx Ltd. | 0.00% | 2.85 | 0.8% | $38.97m | |
| ARGX | argenx SE | 4.22% | 272.30 | 0.0% | $38.23m | |
| SAGE | SAGE Therapeutics, Inc. | 2.03% | 70.86 | 7.6% | $33.60m | |
| PCRX | Pacira Biosciences, Inc. | 1.22% | 62.21 | 9.9% | $30.64m | |
| AXSM | Axsome Therapeutics, Inc. | -2.68% | 58.42 | 1.9% | $26.79m | |
| RVMD | Revolution Medicines, Inc. | 4.07% | 31.99 | 0.0% | $23.38m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.